QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NYSEARCA:GSIE

Goldman Sachs ActiveBeta International Equity ETF (GSIE) Price, Holdings, & News

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free GSIE Stock Alerts
$32.78
+0.05 (+0.15%)
(As of 04:00 PM ET)
Compare
Today's Range
$32.69
▼
$32.90
50-Day Range
$32.14
▼
$34.45
52-Week Range
$28.51
▼
$34.50
Volume
289,731 shs
Average Volume
491,457 shs
Market Capitalization
$3.46 billion
Assets Under Management
$3.48 billion
Dividend Yield
2.62%
Net Expense Ratio
0.25%
Stock AnalysisChartHoldingsOwnershipRatings
GSIE stock logo

About Goldman Sachs ActiveBeta International Equity ETF (NYSEARCA:GSIE)

The Goldman Sachs ActiveBeta International Equity ETF (GSIE) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of stocks in developed markets outside of the US comprising four sub-indices: value, momentum, quality and low volatility. The index uses multiple factors to pick stocks, and each sub-index receives equal weight. GSIE was launched on Nov 6, 2015 and is managed by Goldman Sachs.

GSIE Stock Price History

GSIE ETF News Headlines

March 24, 2024 | investing.com
Goldman Sachs ActiveBeta® Emerging Markets Equity ETF (GEM)
February 19, 2024 | msn.com
Goldman Sachs lifts 2024 S&P 500 target to 5,200 on upbeat profit outlook
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
December 29, 2023 | msn.com
Goldman Sachs ActiveBeta Europe Equity ETF declares quarterly distribution of $0.2722
December 27, 2023 | msn.com
Goldman Sachs ActiveBeta International Equity ETF declares quarterly distribution of $0.1495
November 4, 2023 | marketwatch.com
Goldman Sachs Satellite Strategies Portfolio;Investor
June 27, 2023 | msn.com
Goldman Sachs ActiveBeta(R) World Low Vol Plus Equity ETF declares quarterly distribution of $0.3139
June 27, 2023 | msn.com
Goldman Sachs ActiveBeta International Equity ETF declares quarterly distribution of $0.4488
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
May 19, 2023 | benzinga.com
Goldman Sachs ActiveBeta International Equity ETF (ARCA:GSIE), Quotes and News Summary
See More Headlines
Receive GSIE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Goldman Sachs ActiveBeta International Equity ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer
Goldman Sachs
Fund Name
Goldman Sachs ActiveBeta International Equity ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:GSIE
Inception Date
11/6/2015
Fund Manager
Raj Garigipati, Jamie McGregor
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Goldman Sachs ActiveBeta International Equity Index
Category
Broad Equity
Focus
Strategy
Development Level
Developed Markets
Region
Global ex-U.S.
Number of Holdings
718

Fund Statistics

Assets Under Management
$3.46 billion
Average Daily Volume
$368,435.80
Discount/Premium
0.06%

Administrator, Advisor and Custodian

Administrator
The Bank of New York Mellon Corporation
Advisor
Goldman Sachs Asset Management, L.P.
Custodian
The Bank of New York Mellon Corporation
Distributor
ALPS Distributors, Inc.
Transfer Agent
The Bank of New York Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
N/A
Short Interest
90,600 shs

Miscellaneous

Outstanding Shares
105,700,000
Beta
0.80
Creation Unit
100,000
Creation Fee
$7,000.00
A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Ad Behind the Markets
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Find out more here >>>

Goldman Sachs ActiveBeta International Equity ETF Expenses

TypeGSIEStrategy ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.25%0.46%0.54%0.50%0.51%
Other Expenses0.00%0.42%0.54%0.64%0.58%
Total Expense0.25%0.61%0.70%0.74%0.70%
Fee Waiver0.00%-0.44%-0.55%-0.68%-0.57%
Net Expense0.25%0.51%0.60%0.58%0.58%

Goldman Sachs ActiveBeta International Equity ETF (GSIE) Holdings & Exposure

Top 10 GSIE Holdings

  • Novo Nordisk A/S Class B
    Holding Weight: 2.11%
  • ASML Holding NV
    Holding Weight: 1.49%
  • Nestle SA
    Holding Weight: 1.14%
  • Lvmh Moet Hennessy Louis Vuitton SE
    Holding Weight: 1.13%
  • Novartis AG Registered Shares
    Holding Weight: 0.92%
  • Shell PLC
    Holding Weight: 0.92%
  • AstraZeneca PLC
    Holding Weight: 0.86%
  • Roche Holding AG
    Holding Weight: 0.86%
  • TotalEnergies SE
    Holding Weight: 0.80%
  • SAP SE
    Holding Weight: 0.76%

GSIE Sector Exposure

GSIE Industry Exposure

Full Holdings Details

GSIE ETF - Frequently Asked Questions

How have GSIE shares performed in 2024?

Goldman Sachs ActiveBeta International Equity ETF's stock was trading at $32.66 at the start of the year. Since then, GSIE stock has increased by 0.5% and is now trading at $32.83.
View the best growth stocks for 2024 here.

What does GSIE invest in?

Goldman Sachs ActiveBeta International Equity ETF is a equity fund issued by Goldman Sachs. GSIE focuses on strategy investments and follows the Goldman Sachs ActiveBeta International Equity Index. The fund's investments total to approximately $3.48 billion assets under management.

What stocks does Goldman Sachs ActiveBeta International Equity ETF hold?

GSIE invests in 718 holdings. Some of the stocks in their portfolio include Capital Senior Living (CSU), Royal Bank of Canada (RY), Loews (L), Toronto-Dominion Bank (TD), Cenovus Energy (CVE) and WisdomTree International LargeCap Dividend Fund (DOL).

What is the management fee for Goldman Sachs ActiveBeta International Equity ETF?

Goldman Sachs ActiveBeta International Equity ETF's management fee is 0.25% and has no other recorded expenses or fee waivers. The net expense ratio for GSIE is 0.25%.

What other stocks do shareholders of Goldman Sachs ActiveBeta International Equity ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Goldman Sachs ActiveBeta International Equity ETF investors own include SM Energy (SM), Amedisys (AMED), Bristol-Myers Squibb (BMY), CNA Financial (CNA), Cognizant Technology Solutions (CTSH), Chevron (CVX), eBay (EBAY), Forty Seven (FTSV), Molina Healthcare (MOH) and Skyworks Solutions (SWKS).

Who are Goldman Sachs ActiveBeta International Equity ETF's major shareholders?

Goldman Sachs ActiveBeta International Equity ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include Financial Management Professionals Inc. (0.95%), Insight Wealth Strategies LLC (0.70%), American National Bank (0.43%), Appleton Partners Inc. MA (0.43%), Hennion & Walsh Asset Management Inc. (0.41%) and Atwood & Palmer Inc. (0.38%).

How do I buy shares of Goldman Sachs ActiveBeta International Equity ETF?

Shares of GSIE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:GSIE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media